1. Effect of everolimus on the pharmacokinetics of octreotide long‐acting repeatable in patients with advanced neuroendocrine tumors: An analysis of the randomized phase III RADIANT‐2 trial. Issue 4 (29th December 2016) Authors: Pavel, ME; Becerra, C; Grosch, K; Cheung, W; Hasskarl, J; Yao, JC Journal: Clinical pharmacology & therapeutics Issue: Volume 101:Issue 4(2017) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗